Analystreport

Corcept Therapeutics Incorporated (NASDAQ: CORT) was given a new $30.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock.

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors